Söndag 22 December | 02:16:32 Europe / Stockholm

Prenumeration

2024-11-29 13:24:00

Redeye updates its estimates following MindArk’s weaker-than-expected Q3 report. The company continues to demonstrate strong cost control, and we anticipate solid margins as sales rebound, which we expect to occur already in Q4. Redeye has revised its estimates and valuation based on the report.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/